Lessee, Operating Lease, Liability, to be Paid of BIO-RAD LABORATORIES, INC. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
BIO-RAD LABORATORIES, INC. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2025 was $217,000,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $217,000,000 +$21,500,000 +11% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $230,700,000 +$18,500,000 +8.7% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $241,400,000 +$22,600,000 +10% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $188,800,000 -$40,200,000 -18% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $195,500,000 -$40,800,000 -17% 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 $212,200,000 -$24,900,000 -11% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $218,800,000 +$12,700,000 +6.2% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $229,000,000 +$23,200,000 +11% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $236,300,000 +$19,900,000 +9.2% 31 Dec 2023 10-K 16 Feb 2024 2023 FY
Q3 2023 $237,100,000 +$31,500,000 +15% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $206,100,000 -$14,600,000 -6.6% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $205,800,000 -$29,200,000 -12% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $216,400,000 -$30,400,000 -12% 31 Dec 2022 10-K 17 Feb 2023 2022 FY
Q3 2022 $205,600,000 -$46,400,000 -18% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $220,700,000 -$16,200,000 -6.8% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $235,000,000 -$11,400,000 -4.6% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $246,800,000 -$6,100,000 -2.4% 31 Dec 2021 10-K 11 Feb 2022 2021 FY
Q3 2021 $252,000,000 +$1,300,000 +0.52% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $236,900,000 -$12,200,000 -4.9% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $246,400,000 -$7,500,000 -3% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $252,900,000 -$2,500,000 -0.98% 31 Dec 2020 10-K 16 Feb 2021 2020 FY
Q3 2020 $250,700,000 -$30,300,000 -11% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $249,100,000 -$26,400,000 -9.6% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $253,900,000 -$30,400,000 -11% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $255,400,000 31 Dec 2019 10-K 02 Mar 2020 2019 FY
Q3 2019 $281,000,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $275,500,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $284,300,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.